Terms: = Colorectal cancer AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869 AND Treatment
39 results:
1. Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance.
Boughanem H; Pilo J; García-Flores LA; Arranz I; Ramos-Fernandez M; Ortega-Castan M; Crujeiras AB; Sandoval J; Macias-Gonzalez M
J Transl Med; 2024 May; 22(1):509. PubMed ID: 38802858
[TBL] [Abstract] [Full Text] [Related]
2. Complete mesocolic excision for right hemicolectomy: an updated systematic review and meta-analysis.
De Lange G; Davies J; Toso C; Meurette G; Ris F; Meyer J
Tech Coloproctol; 2023 Nov; 27(11):979-993. PubMed ID: 37632643
[TBL] [Abstract] [Full Text] [Related]
3. Pharmacological targeting of axin2 suppresses cell growth and metastasis in colorectal cancer.
Cheng LZ; Huang DL; Tang ZR; Zhang JH; Xiong T; Zhou C; Zhang NX; Fu R; Cheng YX; Wu ZQ
Br J Pharmacol; 2023 Dec; 180(23):3071-3091. PubMed ID: 37461816
[TBL] [Abstract] [Full Text] [Related]
4. Investigating the WNT/TCF pathway and the value of DCE-MRI in predicting and evaluating the efficacy of neoadjuvant radiotherapy and chemotherapy for locally advanced rectal cancer.
Cheng Q; Rong F; Ye S; Zheng B; Chen X; Ye N; Ling Q; Wu W
Cell Mol Biol (Noisy-le-grand); 2023 Feb; 69(2):95-100. PubMed ID: 37224039
[TBL] [Abstract] [Full Text] [Related]
5. ALKBH5 Drives Immune Suppression Via Targeting axin2 to Promote colorectal cancer and Is a Target for Boosting Immunotherapy.
Zhai J; Chen H; Wong CC; Peng Y; Gou H; Zhang J; Pan Y; Chen D; Lin Y; Wang S; Kang W; To KF; Chen Z; Nie Y; He HH; Sung JJ; Yu J
Gastroenterology; 2023 Aug; 165(2):445-462. PubMed ID: 37169182
[TBL] [Abstract] [Full Text] [Related]
6. Construction of a colorectal cancer Prognostic Risk Model and Screening of Prognostic Risk Genes Using Machine-Learning Algorithms.
Du X; Qi H; Ji W; Li P; Hua R; Hu W; Qi F
Comput Math Methods Med; 2022; 2022():9408839. PubMed ID: 36267311
[TBL] [Abstract] [Full Text] [Related]
7. Microsatellite instability/mismatch repair deficiency and activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland: A case report.
Yang G
Medicine (Baltimore); 2022 Aug; 101(34):e30311. PubMed ID: 36042639
[TBL] [Abstract] [Full Text] [Related]
8. Identification and validation of prognosis-associated DNA repair gene signatures in colorectal cancer.
Song D; Zhang D; Chen S; Wu J; Hao Q; Zhao L; Ren H; Du N
Sci Rep; 2022 Apr; 12(1):6946. PubMed ID: 35484177
[TBL] [Abstract] [Full Text] [Related]
9. Discovery of a Novel Triazolopyridine Derivative as a Tankyrase Inhibitor.
Ryu H; Nam KY; Kim HJ; Song JY; Hwang SG; Kim JS; Kim J; Ahn J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298950
[TBL] [Abstract] [Full Text] [Related]
10. Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated colorectal cancer.
Rajamäki K; Taira A; Katainen R; Välimäki N; Kuosmanen A; Plaketti RM; Seppälä TT; Ahtiainen M; Wirta EV; Vartiainen E; Sulo P; Ravantti J; Lehtipuro S; Granberg KJ; Nykter M; Tanskanen T; Ristimäki A; Koskensalo S; Renkonen-Sinisalo L; Lepistö A; Böhm J; Taipale J; Mecklin JP; Aavikko M; Palin K; Aaltonen LA
Gastroenterology; 2021 Aug; 161(2):592-607. PubMed ID: 33930428
[TBL] [Abstract] [Full Text] [Related]
11. Potential chemopreventive, anticancer and anti-inflammatory properties of a refined artocarpin-rich wood extract of Artocarpus heterophyllus Lam.
Morrison IJ; Zhang J; Lin J; Murray JE; Porter R; Langat MK; Sadgrove NJ; Barker J; Zhang G; Delgoda R
Sci Rep; 2021 Mar; 11(1):6854. PubMed ID: 33767225
[TBL] [Abstract] [Full Text] [Related]
12. Targeting a Lipid Desaturation Enzyme, SCD1, Selectively Eliminates Colon cancer Stem Cells through the Suppression of Wnt and NOTCH Signaling.
Yu Y; Kim H; Choi S; Yu J; Lee JY; Lee H; Yoon S; Kim WY
Cells; 2021 Jan; 10(1):. PubMed ID: 33430034
[TBL] [Abstract] [Full Text] [Related]
13. Cleistanthin A induces apoptosis and suppresses motility of colorectal cancer cells.
Jearawuttanakul K; Khumkhrong P; Suksen K; Reabroi S; Munyoo B; Tuchinda P; Borwornpinyo S; Boonmuen N; Chairoungdua A
Eur J Pharmacol; 2020 Dec; 889():173604. PubMed ID: 32980346
[TBL] [Abstract] [Full Text] [Related]
14. Lactobacillus species inhibitory effect on colorectal cancer progression through modulating the Wnt/β-catenin signaling pathway.
Ghanavati R; Akbari A; Mohammadi F; Asadollahi P; Javadi A; Talebi M; Rohani M
Mol Cell Biochem; 2020 Jul; 470(1-2):1-13. PubMed ID: 32419125
[TBL] [Abstract] [Full Text] [Related]
15. Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the treatment of Colon cancer.
Shirai F; Mizutani A; Yashiroda Y; Tsumura T; Kano Y; Muramatsu Y; Chikada T; Yuki H; Niwa H; Sato S; Washizuka K; Koda Y; Mazaki Y; Jang MK; Yoshida H; Nagamori A; Okue M; Watanabe T; Kitamura K; Shitara E; Honma T; Umehara T; Shirouzu M; Fukami T; Seimiya H; Yoshida M; Koyama H
J Med Chem; 2020 Apr; 63(8):4183-4204. PubMed ID: 32202790
[TBL] [Abstract] [Full Text] [Related]
16. Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for colorectal cancer.
Liu X; Bing Z; Wu J; Zhang J; Zhou W; Ni M; Meng Z; Liu S; Tian J; Zhang X; Li Y; Jia S; Guo S
Med Sci Monit; 2020 Jan; 26():e918906. PubMed ID: 31893510
[TBL] [Abstract] [Full Text] [Related]
17. colorectal cancer Care Among Young Adult Patients After the Dependent Coverage Expansion Under the Affordable Care Act.
Nogueira L; Chawla N; Han X; Jemal A; Yabroff KR
J Natl Cancer Inst; 2020 Oct; 112(10):1063-1066. PubMed ID: 31854444
[TBL] [Abstract] [Full Text] [Related]
18. Molecular characterization of colorectal cancer using whole-exome sequencing in a Taiwanese population.
Chang YS; Lee CC; Ke TW; Chang CM; Chao DS; Huang HY; Chang JG
Cancer Med; 2019 Jul; 8(8):3738-3747. PubMed ID: 31127692
[TBL] [Abstract] [Full Text] [Related]
19. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis.
Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J
J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942
[TBL] [Abstract] [Full Text] [Related]
20. RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model.
Mizutani A; Yashiroda Y; Muramatsu Y; Yoshida H; Chikada T; Tsumura T; Okue M; Shirai F; Fukami T; Yoshida M; Seimiya H
Cancer Sci; 2018 Dec; 109(12):4003-4014. PubMed ID: 30238564
[TBL] [Abstract] [Full Text] [Related]
[Next]
